- Prostate cancer: Systemic treatment for hormone-sensitive and castration-resistant prostate cancer
- Testicular cancer: all aspects of treatment and follow-up
Dr Alison Reid is a Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust. She specialises in the treatment of prostate and testicular cancers.
She joined the Royal Marsden in 2005 and worked in early Phase clinical trials before pursuing a PhD in castration-resistant prostate cancer (CRPC) at The Institute of Cancer Research. During her PhD, she was published widely on the early clinical development of abiraterone acetate for prostate cancer and in implementing molecular studies for patient stratification.
For her research, Dr Reid received awards from the American Society of Clinical Oncology, the European Society of Medical Oncology and the American Association for Cancer Research. Dr Reid was appointed to a medical oncology consultant position in 2014.
She leads the prostate medical oncology service in RM Sutton and Kingston and serves as a principle investigator on therapeutic trials for prostate cancer. She is also committed to testicular cancer research focusing on understanding the mechanisms of treatment resistance and survivorship endeavours.
She is a member of the EORTC genitourinary group, the NCRI teenage young adult and germ cell tumours clinical studies group and the RM partners Urology Pathway Group.